EVANIUM
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
EVANIUM - overview
Established
2019
Location
Regensburg, -, Germany
Primary Industry
Biotechnology
About
Established in 2019, and based in Germany, founded by Felix Rolka (CEO), David Ofner (CTO) and Carlo Werkmann, EVANIUM Healthcare GmbH operates as a B2B life-science ingredient developer and drug delivery technology provider. The company provides bioavailability-enhanced nutraceutical ingredients, functional food actives, nutricosmetic compounds, and pharmaceutical-grade plant-based ingredient formulations.
Current Investors
Foodlabs, Denava Ag, Feast Ventures
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Biopharmaceuticals
Website
www.evanium.de
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.